LGND vs. VOO

In the year-to-date period, LGND achieves a -4.63% return, which is significantly lower than VOO's 0.90% return. Over the past 10 years, LGND has underperformed VOO with an annualized return of 6.82%, while VOO has yielded a comparatively higher 12.81% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Ligand Pharmaceuticals Incorporated (LGND) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current LGND Sharpe Ratio is 0.54, which is comparable to the VOO Sharpe Ratio of 0.74. The chart below compares the historical Sharpe Ratios of LGND and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

LGND has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.29%.

The maximum LGND drawdown since its inception was -93.34%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for LGND and VOO.

Ligand Pharmaceuticals Incorporated (LGND) has a higher volatility of 7.32% compared to Vanguard S&P 500 ETF (VOO) at 4.84%. This indicates that LGND's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.